123 related articles for article (PubMed ID: 33894415)
1. Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Gu Y; Hu D; Xin Y; Shao J
Biochem Biophys Res Commun; 2021 Jun; 557():280-287. PubMed ID: 33894415
[TBL] [Abstract][Full Text] [Related]
2. The interface targeting hnRNPA2B1 regulates the repression of transthyretin against human retinal microvascular endothelial cells in high-glucose environment.
Tian Y; Ye L; Shao J; Xin Y
Diabet Med; 2023 Sep; 40(9):e15125. PubMed ID: 37186403
[TBL] [Abstract][Full Text] [Related]
3. A novel transthyretin/STAT4/miR-223-3p/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy.
Shao J; Fan G; Yin X; Gu Y; Wang X; Xin Y; Yao Y
Mol Cell Endocrinol; 2019 Dec; 498():110541. PubMed ID: 31415795
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin Exerts Pro-Apoptotic Effects in Human Retinal Microvascular Endothelial Cells Through a GRP78-Dependent Pathway in Diabetic Retinopathy.
Shao J; Yin Y; Yin X; Ji L; Xin Y; Zou J; Yao Y
Cell Physiol Biochem; 2017; 43(2):788-800. PubMed ID: 28950253
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin represses neovascularization in diabetic retinopathy.
Shao J; Yao Y
Mol Vis; 2016; 22():1188-1197. PubMed ID: 27746673
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.
Fan G; Gu Y; Zhang J; Xin Y; Shao J; Giampieri F; Battino M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847264
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Shao J; Zhang Y; Fan G; Xin Y; Yao Y
BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin-induced increase in circ_0007411 represses neovascularization of human retinal microvascular endothelial cells in hyperglycemia via the miR-548m/PTPN12/SKP1/EGFR pathway.
Hu D; Tian Y; Ye L; Xin Y; Shao J
Ann Transl Med; 2022 May; 10(10):556. PubMed ID: 35722376
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.
Tang W; Guo J; Gu R; Lei B; Ding X; Ma J; Xu G
Mol Vis; 2020; 26():64-75. PubMed ID: 32165827
[TBL] [Abstract][Full Text] [Related]
10. Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.
Shao J; Yao Y
Int J Ophthalmol; 2016; 9(6):809-15. PubMed ID: 27366679
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3p/vascular endothelial growth factor C.
Yan H; Yao P; Hu K; Li X; Li H
J Diabetes Investig; 2021 Nov; 12(11):1948-1957. PubMed ID: 34137197
[TBL] [Abstract][Full Text] [Related]
13. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
Han N; Tian W; Yu N; Yu L
J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
[TBL] [Abstract][Full Text] [Related]
14. MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3.
Wang C; Lin Y; Fu Y; Zhang D; Xin Y
Pflugers Arch; 2020 Nov; 472(11):1607-1618. PubMed ID: 32648125
[TBL] [Abstract][Full Text] [Related]
15. Silencing circ_0001879 inhibits the proliferation and migration of human retinal microvascular endothelial cells under high-glucose conditions via modulating miR-30-3p.
Zeng Q; Liu J
Gene; 2020 Nov; 760():144992. PubMed ID: 32721474
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2.
Wang J; Yao Y; Wang K; Li J; Chu T; Shen H
Acta Diabetol; 2020 Dec; 57(12):1435-1443. PubMed ID: 32661705
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
Zou J; Liu KC; Wang WP; Xu Y
Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
[TBL] [Abstract][Full Text] [Related]
18. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
Xia F; Sun JJ; Jiang YQ; Li CF
J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
Yu L; Fu J; Yu N; Wu Y; Han N
Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
